Enzymatics Overview

  • Founded
  • 2006
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 70
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $114M
Latest Deal Amount

Enzymatics General Information

Description

Producer of enzymes for genomic sequencing machines. The company's products are used by commercial entities engaged in the development, manufacture and distribution of platforms dedicated to nucleic acid identification.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Parent Company
Primary Office
  • 100 Cummings Center
  • Suite 407J
  • Beverly, MA 01915
  • United States
+1 (888) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Enzymatics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 16-Dec-2014 $114M 00.000 00000 Completed Clinical Trials - Phase 1
2. Later Stage VC 14-Aug-2013 00.000 00.000 Completed Clinical Trials - Phase 1
1. Convertible Debt 01-Sep-2006 $1.6M $1.6M Completed Startup
To view Enzymatics’s complete valuation and funding history, request access »

Enzymatics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Producer of enzymes for genomic sequencing machines. The company's products are used by commercial entities engaged in t
Biotechnology
Beverly, MA
70 As of 2015
00.000
0000 0000-00-00
000000&0 00.000

000 0000

ore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip
0000000000000
Ipswich, MA
000 As of 0000
0000000000

0000 000

nim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequ
0000000000000
Wilmington, MA
000 As of 0000
0000 0000-00-00
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Enzymatics Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
New England Biolabs Corporation Ipswich, MA 000 0000000000
0000 0000000000 Corporate Backed or Acquired Wilmington, MA 000 000000&0
0000 00000 0000000 Corporation Rockville, MD 0000000000
00000000 Private Debt Financed Mountain View, CA 00 000000000 -
000000000 00000000 Corporate Backed or Acquired Madison, WI 00 000000&0
You’re viewing 5 of 14 competitors. Get the full list »

Enzymatics Executive Team (15)

Name Title Board Seat Contact Info
Jack Percoskie Chief Financial Officer
Danielle Sallese Director of Supply Chain Solutions
Steve Regan Senior Director of Reagent Operations
You’re viewing 3 of 15 executive team members. Get the full list »

Enzymatics Board Members (3)

Name Representing Role Since
George Church Ph.D Self Chairman, Scientific Advisory Board 000 0000
You’re viewing 1 of 3 board members. Get the full list »

Enzymatics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Enzymatics Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Keswick Ventures Venture Capital Minority 000 0000 000000 0
PBM Capital Group PE/Buyout Minority 000 0000 000000 0
To view Enzymatics’s complete investors history, request access »

Enzymatics Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 06-Sep-2013 000000000000000000 0000 Drug Discovery
To view Enzymatics’s complete acquisitions history, request access »

Enzymatics Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000000 06-Sep-2013 000000000000000000 0000 Completed
  • 0000000000
To view Enzymatics’s complete exits history, request access »